GLP-1s and tackling weight loss spend

Addressing the cost of weight loss medications

Weight loss drugs are going to be one of the top drivers of healthcare costs for 2024. What should employers do about it?

Join us for a discussion with John Coleman (CEBS at Mercer), Jane Suttmeier (Account Executive at Forma), and Megan Burns (Heads of Benefits Strategy at Forma) on how employers can tackle weight loss spend.

The group will cover:

• How different types of GLP-1 medications treat different health conditions
• Why a weight management program makes sense for your employees
• How a Speciality HRA can provide reimbursement for healthcare expenses including GLP1's that may be excluded on your medical plan